Exagen Inc.(NasdaqGM:XGN) dropped from Russell 2500 Growth Index
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.97 USD | 0.00% | +1.81% | -1.01% |
05-14 | Cantor Fitzgerald Adjusts Price Target on Exagen to $7 From $5, Maintains Overweight Rating | MT |
05-13 | Exagen Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.01% | 34.23M | |
+22.65% | 87.14B | |
-23.68% | 75.59B | |
+1.76% | 26.78B | |
+3.99% | 17.89B | |
-13.47% | 16.44B | |
+2.68% | 15.68B | |
+69.13% | 13.3B | |
+74.99% | 13.06B | |
+3.11% | 12.54B |
- Stock Market
- Equities
- XGN Stock
- News Exagen Inc.
- Exagen Inc.(NasdaqGM: XGN) dropped from Russell 2500 Growth Index